# Teriparatide and Strontium Ranelate Head-To-Head Comparison Trial

> **NCT00239629** · PHASE4 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 73 (—)

## Conditions studied

- Postmenopausal Osteoporosis

## Interventions

- **DRUG:** Teriparatide
- **DRUG:** Strontium ranelate
- **PROCEDURE:** Transiliac bone biopsy

## Key facts

- **NCT ID:** NCT00239629
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-09
- **Primary completion:** —
- **Final completion:** 2007-01
- **Target enrollment:** 73 (—)
- **Last updated:** 2007-06-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00239629

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00239629, "Teriparatide and Strontium Ranelate Head-To-Head Comparison Trial". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT00239629. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*